ROUTE,

DATE MECHANIS
NAME OF DOSAGE INDICA- CONTRA- SIDE CLIENT’S NURSING
ADMINIS- M OF
DRUG AND FRE- TION INDICATION EFFECTS RESPONSE RESPONSIBILITIES
TERED ACTION
QUENCY
Generic May 35, Parecoxib A selective Managemen  Hypersensitivity  Ulcer The client’s Before Administration:
Name: 2021 40 mg cyclo- t of pain. to parecoxib.  GI bleeding pain scale  Check the doctor’s
 parecoxib SIVP every oxygenase-2  Jaundice subsided order.
May 7, 12 hours (COX-2)  Slow heart from 8/10 to  Observe for the 12
Brand Name: 2021 inhibitor rate 3/10. rights of drug
 Dynastat primarily  High/low administration.
responsible to blood
reduce  Assess the client’s
Classification: pressure
mediators of hypersensitivity to
 Enzyme  Swelling
pain and drug.
inhibitor  Rash
inflammation.  Assess client's
 Itching condition before
Pregnancy Its action is due
 Difficulty in therapy and regularly
Category: C to inhibition of
breathing thereafter to monitor
prostaglandin
 Back pain drug effectiveness.
synthesis via
inhibition of
COX-2. During Administration:
 Administer Dynastat
40 mg via SIVP.

After administration:
 Assess patient for this
medicine may cause
dizziness,
lightheadedness.

 Provide further
comfort measures to
 reduce pain.
 May cause drowsiness
and dizziness. Instruct
to avoid activities
requiring alertness.

 Advise patient to
notify health care
professional if
dizziness, back pain,
feeling numb, stomach
upset including
nausea, vomiting,
heartburn, indigestion,
cramps constipation,
diarrhea, and skin
rash.